Higher circulating bile acid concentrations in obese patients with type 2 diabetes

Annals of Clinical Biochemistry

Volumn 50, Issue 4, 2013, Pages 360-364

  Vincent, Royce P ^a   Omar, Sohail ^a   Ghozlan, Samer ^a   Taylor, David R ^a   Cross, Gemma ^a   Sherwood, Roy A ^a   Fandriks, Lars ^b   Olbers, Torsten ^b   Werling, Malin ^b   Alaghband Zadeh, Jamshid ^a   le Roux, Carel W ^a,b,c  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Bile acids; Glucagon like peptide 1; TGR5 receptor; Type 2 diabetes mellitus

Indexed keywords

BILE ACID; GLUCOSE; GLYCINE; GLYCINE CONJUGATED BILE ACID; TAURINE; TAURINE CONJUGATED BILE ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BILE ACID BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MEAL; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; STIMULUS RESPONSE; TANDEM MASS SPECTROMETRY;

EID: 84890250615     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/0004563212473450     Document Type: Article

References (20)

1. Lefebvre P, Cariou B, Lien F, Kuipers F and Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 2009; 89: 147-191.
2. Prawitt J, Caron S and Staels B. Bile acid metabolism and the pathogenesis of type 2 diabetes. Curr Diab Rep 2011; 11: 160-166.
3. Prawitt J and Staels B. Bile acid sequestrants: glucoselowering mechanisms. Metabol Syndr Relat Disord 2010; 8: 3-8.
4. Staels B and Fonseca VA. Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration. Diabetes Care 2009; 32: 237-245.
5. Monte MJ, Marin JJ, Antelo A and Vazquez-Tato J. Bile acids: chemistry, physiology, and pathophysiology. World J Gastroenterol 2009; 15: 804-816.
6. Martinez-Augustin O and Sanchez de Medina F. Intestinal bile acid physiology and pathophysiology. World J Gastroenterol 2008; 14: 5630-5640.
7. Wang L, Lee YK, Bundman D, et al. Redundant pathways for negative feedback regulation of bile acid production. Dev Cell 2002; 2: 721-731.
8. Li T, Jahan A and Chiang JY. Bile acids and cytokines inhibit the human cholesterol 7 alpha-hydroxylase gene via the JNK/c-jun pathway in human liver cells. Hepatology 2006; 43: 1202-1210.
9. Shaham O, Wei R, Wang TJ, et al. Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol 2008; 4: 214-223.
10. Zhao X, Peter A, Fritsche J, et al. Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at? Am J Physiol Endocrinol Metab 2009; 296: 384-393.
11. Lucio M, Fekete A, Weigert C, et al. Insulin sensitivity is reflected by characteristic metabolic fingerprints - a Fourier transform mass spectrometric non-targeted metabolomics approach. PLoS One 2010; 5: e13317.
12. Roberts RE, Glicksman C, Alaghband-Zadeh J, Sherwood RA, Akuji N and le Roux CW. The relationship between post-prandial bile acid concentration, GLP-1, PYY and ghrelin. Clin Endocrinol (Oxf) 2010; 74: 67-72.
13. Cariou B, Chetiveaux M, Zaïr Y, et al. Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults. Nutr Metab 2011; 8: 48-53.
14. Vilsbøll T, Krarup T, Deacon CF, Madsbad S and Holst JJ. Reduced post-prandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 2001; 50: 609-613.
15. Li T, Chanda D, Zhang Y, Choi HS and Chiang JYL. Glucose stimulates cholesterol 7a-hydroxylase gene transcription in human hepatocytes. J Lipid Res 2010; 51: 832-842.
16. Glicksman C, Pournaras DJ, Wright M, et al. Postprandial plasma bile acid responses in normal weight and obese subjects. Ann Clin Biochem 2010; 47: 482-484.
17. Tagliacozzi D, Mozzi AF, Casetta B, et al. Quantitative analysis of bile acids in human plasma by liquid chromatography- electrospray tandem mass spectrometry: a simple and rapid one-step method. Clin Chem Lab Med 2003; 41: 1633-1641.
18. Song KH, Li T, Owsley E, Strom S and Chiang JY. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression. Hepatology 2009; 49: 297-305.
19. Park WH and Pak YK. Insulin-dependent suppression of cholesterol 7a-hydroxylase is a possible link between glucose and cholesterol metabolism. Exp Mol Med 2011; 43: 571-579.
20. VanPatten S, Karkanias GB, Rossetti L and Cohen DE. Intracerebroventricular leptin regulates hepatic cholesterol metabolism. Biochem J 2004; 379: 229-233.